MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, TVRD had -$10,880K decrease in cash & cash equivalents over the period.

Cash Flow Overview

Change in Cash
-$10,880K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Cash acquired in connection with...
    • Maturities of short-term investm...
    • Stock-based compensation expense
    • Others
Negative Cash Flow Breakdown
    • Purchases of short-term investme...
    • Net loss
    • Change in fair value of converti...
    • Others

Cash Flow
2025-12-31
Net loss
-18,214
Depreciation and amortization expense
95
Stock-based compensation expense
1,399
Change in fair value of convertible notes
-7,810
Non-cash lease expense
72
Accretion of net discounts on short-term investments
200
Interest accrued on convertible notes
651
Prepaid expenses and other assets
308
Accounts payable and accrued expenses
919
Operating lease liabilities
-103
Net cash used in operating activities
-23,499
Purchases of short-term investments
31,486
Maturities of short-term investments
21,402
Net cash used in investing activities
-10,084
Cash acquired in connection with the merger
24,992
Payments for merger transaction costs
2,821
Proceeds from exercise of stock options
532
Net cash provided by financing activities
22,703
Net (decrease) increase in cash and cash equivalents
-10,880
Cash and cash equivalents - beginning of year
31,614
Cash and cash equivalents - end of year
20,734
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Cash acquired inconnection with the merger$24,992K Proceeds from exercise ofstock options$532K Net cash provided byfinancing activities$22,703K Canceled cashflow$2,821K Net (decrease)increase in cash and cash...-$10,880K Canceled cashflow$22,703K Stock-based compensationexpense$1,399K Accounts payable andaccrued expenses$919K Interest accrued onconvertible notes$651K Depreciation andamortization expense$95K Non-cash lease expense$72K Maturities of short-terminvestments$21,402K Payments for mergertransaction costs$2,821K Net cash used inoperating activities-$23,499K Canceled cashflow$3,136K Net cash used ininvesting activities-$10,084K Canceled cashflow$21,402K Net loss-$18,214K Change in fair value ofconvertible notes-$7,810K Prepaid expenses andother assets$308K Accretion of net discountson short-term...$200K Operating leaseliabilities-$103K Purchases of short-terminvestments$31,486K

Tvardi Therapeutics, Inc. (TVRD)

Tvardi Therapeutics, Inc. (TVRD)